377 related articles for article (PubMed ID: 27644118)
1. Very low protein diets supplemented with keto-analogues in ESRD predialysis patients and its effect on vascular stiffness and AVF Maturation.
David C; Peride I; Niculae A; Constantin AM; Checherita IA
BMC Nephrol; 2016 Sep; 17(1):131. PubMed ID: 27644118
[TBL] [Abstract][Full Text] [Related]
2. Is there a role for ketoacid supplements in the management of CKD?
Shah AP; Kalantar-Zadeh K; Kopple JD
Am J Kidney Dis; 2015 May; 65(5):659-73. PubMed ID: 25682182
[TBL] [Abstract][Full Text] [Related]
3. The effect of a keto acid supplement on the course of chronic renal failure and nutritional parameters in predialysis patients and patients on regular hemodialysis therapy: the Hungarian Ketosteril Cohort Study.
Zakar G;
Wien Klin Wochenschr; 2001 Sep; 113(17-18):688-94. PubMed ID: 11603104
[TBL] [Abstract][Full Text] [Related]
4. Short-term effects of a very-low-protein diet supplemented with ketoacids in nondialyzed chronic kidney disease patients.
Feiten SF; Draibe SA; Watanabe R; Duenhas MR; Baxmann AC; Nerbass FB; Cuppari L
Eur J Clin Nutr; 2005 Jan; 59(1):129-36. PubMed ID: 15354199
[TBL] [Abstract][Full Text] [Related]
5. Arterial stiffness and arteriovenous fistula failure of maturation.
Masengu A; Hanko JB; Maxwell AP
J Vasc Access; 2016 Nov; 17(6):477-482. PubMed ID: 27646925
[TBL] [Abstract][Full Text] [Related]
6. Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function.
Korsheed S; Eldehni MT; John SG; Fluck RJ; McIntyre CW
Nephrol Dial Transplant; 2011 Oct; 26(10):3296-302. PubMed ID: 21317408
[TBL] [Abstract][Full Text] [Related]
7. Arterial stiffness alone does not explain arteriovenous fistula outcomes.
McGrogan DG; Stringer S; Cockwell P; Jesky M; Ferro C; Maxwell AP; Inston NG
J Vasc Access; 2018 Jan; 19(1):63-68. PubMed ID: 29076519
[TBL] [Abstract][Full Text] [Related]
8. Association of Vitamin D Metabolites With Arterial Function in the Hemodialysis Fistula Maturation Study.
van Ballegooijen AJ; Zelnick L; Hoofnagle AN; Hamburg NM; Robinson-Cohen C; Roy-Chaudhury P; Cheung AK; Shiu YT; de Boer IH; Himmelfarb J; Beck G; Imrey PB; Kusek JW; Kestenbaum B;
Am J Kidney Dis; 2017 Jun; 69(6):805-814. PubMed ID: 28359657
[TBL] [Abstract][Full Text] [Related]
9. Reduction of morbidity related to emergency access to dialysis with very low protein diet supplemented with ketoacids (VLPD+KA).
Duenhas M; Gonçalves E; Dias M; Leme G; Laranja S
Clin Nephrol; 2013 May; 79(5):387-93. PubMed ID: 23557788
[TBL] [Abstract][Full Text] [Related]
10. [Effects of keto/amino acids and a low-protein diet on the nutritional status of patients with Stages 3B-4 chronic kidney disease].
Milovanova SY; Milovanov YS; Taranova MV; Dobrosmyslov IA
Ter Arkh; 2017; 89(6):30-33. PubMed ID: 28745686
[TBL] [Abstract][Full Text] [Related]
11. Conservative long-term treatment of chronic renal failure with keto acid and amino acid supplementation.
Schmicker R; Vetter K; Lindenau K; Fröhling PT; Kokot F
Infusionsther Klin Ernahr; 1987 Oct; 14 Suppl 5():34-8. PubMed ID: 3125108
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of arteriovenous fistula creation, effect of preoperative vein mapping and predictors of fistula success in incident haemodialysis patients: A single-centre experience.
Lee KG; Chong TT; Goh N; Achudan S; Tan YL; Tan RY; Choong HL; Tan CS
Nephrology (Carlton); 2017 May; 22(5):382-387. PubMed ID: 27042772
[TBL] [Abstract][Full Text] [Related]
13. Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: a historical cohort controlled study.
Bellizzi V; Chiodini P; Cupisti A; Viola BF; Pezzotta M; De Nicola L; Minutolo R; Barsotti G; Piccoli GB; Di Iorio B
Nephrol Dial Transplant; 2015 Jan; 30(1):71-7. PubMed ID: 25082793
[TBL] [Abstract][Full Text] [Related]
14. Mineral Metabolism Disturbances and Arteriovenous Fistula Maturation.
Kubiak RW; Zelnick LR; Hoofnagle AN; Alpers CE; Terry CM; Shiu YT; Cheung AK; de Boer IH; Robinson-Cohen C; Allon M; Dember LM; Feldman HI; Himmelfarb J; Huber TS; Roy-Chaudhury P; Vazquez MA; Kusek JW; Beck GJ; Imrey PB; Kestenbaum B;
Eur J Vasc Endovasc Surg; 2019 May; 57(5):719-728. PubMed ID: 31000459
[TBL] [Abstract][Full Text] [Related]
15. Arteriovenous fistula in dialysis patients: Factors implicated in early and late AVF maturation failure.
Bashar K; Conlon PJ; Kheirelseid EA; Aherne T; Walsh SR; Leahy A
Surgeon; 2016 Oct; 14(5):294-300. PubMed ID: 26988630
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of keto acid--amino acid supplementation in patients with chronic renal insufficiency receiving a low-protein diet and recombinant human erythropoietin--a randomized controlled trial.
Teplan V; Schück O; Votruba M; Poledne R; Kazdová L; Skibová J; Malý J
Wien Klin Wochenschr; 2001 Sep; 113(17-18):661-9. PubMed ID: 11603100
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the Essential Amino Acids and Keto-Analogues on the CKD progression rate in real practice in Russia - city nephrology registry data for outpatient clinic.
Zemchenkov A; Konakova IN
BMC Nephrol; 2016 Jul; 17(1):62. PubMed ID: 27389019
[TBL] [Abstract][Full Text] [Related]
18. A controlled study of supplementation with essential amino acids and alpha-keto acids in the conservative management of patients with chronic renal failure.
Hecking E; Andrzejewski L; Prellwitz W; Opferkuch W; Müller D; Port FK
Z Ernahrungswiss; 1982 Dec; 21(4):299-311. PubMed ID: 6758383
[TBL] [Abstract][Full Text] [Related]
19. The impact of arteriovenous fistulas on aortic stiffness in patients with chronic kidney disease.
Utescu MS; LeBoeuf A; Chbinou N; Desmeules S; Lebel M; Agharazii M
Nephrol Dial Transplant; 2009 Nov; 24(11):3441-6. PubMed ID: 19509025
[TBL] [Abstract][Full Text] [Related]
20. Effect of far infrared therapy on arteriovenous fistula maturation: an open-label randomized controlled trial.
Lin CC; Yang WC; Chen MC; Liu WS; Yang CY; Lee PC
Am J Kidney Dis; 2013 Aug; 62(2):304-11. PubMed ID: 23474008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
